Evidence map›Paper›PMID 40052110›Full record

Articlenpj metabolic health and disease2025

AMPK phosphosite profiling by label-free mass spectrometry reveals a multitude of mTORC1-regulated substrates.

William J Smiles, Ashley J Ovens, Dingyi Yu, Naomi X Y Ling, Andrea C Poblete Goycoolea, Kaitlin R Morrison, Emmanuel O Murphy, Astrid Glaser, Sophie F Monks O'Byrne, Scott Taylor and 10 more

Abstract read
In one paragraph

Article in npj metabolic health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

William J Smiles *Metabolic Signalling Laboratory, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065 Australia.
Ashley J Ovens *Protein Engineering in Immunity and Metabolism, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065 Australia.
Dingyi YuProtein Chemistry and Metabolism, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065 Australia.
Naomi X Y LingMetabolic Signalling Laboratory, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065 Australia.
Andrea C Poblete GoycooleaMetabolic Signalling Laboratory, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065 Australia.
Kaitlin R MorrisonFlinders Health and Medical Research Institute, Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, SA 5042 Australia.
Emmanuel O MurphyMetabolic Signalling Laboratory, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065 Australia.
Astrid GlaserGenome Stability Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065 Australia.
Sophie F Monks O'ByrneGenome Stability Unit, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065 Australia.
Scott TaylorCancer and RNA Biology, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065 Australia.
Alistair M ChalkCancer and RNA Biology, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065 Australia.
Carl R WalkleyCancer and RNA Biology, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065 Australia.
Luke M McAloonDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, VIC 3052 Australia.
John W ScottDrug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Parkville, VIC 3052 Australia.
Bruce E KempProtein Chemistry and Metabolism, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065 Australia.
Ashfaqul HoqueMetabolic Signalling Laboratory, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065 Australia.
Christopher G LangendorfProtein Engineering in Immunity and Metabolism, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065 Australia.
Janni PetersenFlinders Health and Medical Research Institute, Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, SA 5042 Australia.
Sandra GalicMetabolic Signalling Laboratory, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065 Australia.
Jonathan S OakhillMetabolic Signalling Laboratory, St. Vincent's Institute of Medical Research, Fitzroy, VIC 3065 Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nutrient-sensitive protein kinases AMPK and mTORC1 form a fundamental negative feedback loop that governs cell growth and proliferation. mTORC1 phosphorylates α2-S345 in the AMPK αβγ heterotrimer to suppress its activity and promote cell proliferation under nutrient stress conditions. Whether AMPK contains other functional mTORC1 substrates is unknown. Using mass spectrometry, we generated precise stoichiometry profiles of phosphorylation sites across all twelve AMPK complexes expressed in proliferating human cells and identified seven sites displaying sensitivity to pharmacological mTORC1 inhibition. These included the abundantly phosphorylated residues β1-S182 and β2-S184, which were confirmed as mTORC1 substrates on purified AMPK, and four residues in the unique γ2 N-terminal extension. β-S182/184 phosphorylation was elevated in α1-containing complexes relative to α2, an effect attributed to the α-subunit serine/threonine-rich loop. Mutation of β1-S182 to non-phosphorylatable Ala had no effect on basal and ligand-stimulated AMPK activity; however, β2-S184A mutation increased nuclear AMPK activity, enhanced cell proliferation under nutrient stress and altered expression of genes implicated in glucose metabolism and Akt signalling. Our results indicate that mTORC1 directly or indirectly phosphorylates multiple AMPK residues that may contribute to metabolic rewiring in cancerous cells.

Indexed as

BiochemistryBiological techniquesCancer

Identifiers

PMID40052110
PMCPMC11879883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.